1101303

HP Halden Pharma AS — FEI 3002608066

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 3, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Halden (Norway)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
202721 CFR 211.192Investigations of discrepancies, failures
890721 CFR 314.81(b)(1)(ii)Contamination, chemical or physical change, deterioration